Clik here to view.
NovaBay Pharmaceuticals Announces the Launch of DERMAdoctor’s TikTok Store in...
EMERYVILLE, Calif. NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) announces the expansion of its lifestyle promotional video campaigns on TikTok and its Chinese counterpart Douyin to reach new...
View ArticleClik here to view.
Aurion Biotech Expands Its Leadership Team
SEATTLE, BOSTON & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has appointed Sherita Hall as...
View ArticleClik here to view.
Aurion Biotech Appoints Jonathan Sparks, JD, PhD as Chief Legal Officer
SEATTLE, BOSTON & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has appointed Dr. Jonathan...
View ArticleClik here to view.
ユーサウンドがTWS、補聴器、スマートメガネのバッテリー寿命を強化する高性能ASICリニアオーディオアンプを発表
オーストリア・グラーツ （ビジネスワイヤ） — MEMS技術ベースのヒアラブル・ウエアラブル向けオーディオソリューションを提供する主要企業のユーサウンドは、ユーサウンドMEMSスピーカー駆動用に設計した最新のASICリニアオーディオアンプ「Tarvos 1.0 UC-P3010」のリリースを発表します。...
View ArticleClik here to view.
USound发布高性能ASIC线性音频放大器，提高真无线立体声装置、助听器和智能眼镜的电池寿命
奥利地格拉茨 (美国商业资讯)–USound是面向可听戴和可穿戴设备提供基于微机电系统(MEMS)技术的音频解决方案的领先供应商。该公司宣布推出最新的ASIC线性音频放大器Tarvos 1.0 UC-P3010，专用于驱动USound MEMS扬声器。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
ユーサウンドがTWS、補聴器、スマートメガネのバッテリー寿命を強化する高性能ASICリニアオーディオアンプを発表
オーストリア・グラーツ （ビジネスワイヤ） — MEMS技術ベースのヒアラブル・ウエアラブル向けオーディオソリューションを提供する主要企業のユーサウンドは、ユーサウンドMEMSスピーカー駆動用に設計した最新のASICリニアオーディオアンプ「Tarvos 1.0 UC-P3010」のリリースを発表します。...
View ArticleClik here to view.
USound发布高性能ASIC线性音频放大器，提高真无线立体声装置、助听器和智能眼镜的电池寿命
奥利地格拉茨 (美国商业资讯)–USound是面向可听戴和可穿戴设备提供基于微机电系统(MEMS)技术的音频解决方案的领先供应商。该公司宣布推出最新的ASIC线性音频放大器Tarvos 1.0 UC-P3010，专用于驱动USound MEMS扬声器。 本新闻稿包含多媒体。此处查看新闻稿全文：...
View ArticleClik here to view.
Conrad N. Hilton Foundation Awards more than $175 million from April through...
WESTLAKE VILLAGE, Calif. The Conrad N. Hilton Foundation announced today that the board of directors approved more than $175 million, including program-related investments, in the second and third...
View ArticleClik here to view.
STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022
LAKE FOREST, Calif. STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported preliminary sales for the fourth quarter...
View ArticleClik here to view.
Novaliq计划于2023年7月在欧盟提交CyclASol®用于治疗干眼症的上市许可申请
德国海德堡和美国马萨诸塞州剑桥 (美国商业资讯)–Novaliq是一家生物制药公司，专注于基于独家EyeSol®无水技术的同类首创一流眼科治疗药物。公司今天宣布计划提交CyclASol®（环孢素眼药水）的上市许可申请(MAA)。这将是欧盟首款用于治疗干眼症(DED)的抗炎产品。...
View ArticleClik here to view.
EyeBio Announces First Asset in Innovative Pipeline of Retinal Disease...
LONDON & NEW YORK Eyebiotech Limited (EyeBio), a privately held ophthalmology biotechnology company dedicated to developing and delivering a new generation of therapies to patients with...
View ArticleClik here to view.
HPO, in Collaboration with Eastman, Announces Upcoming Launch of High Energy...
CHARLOTTE, N.C. Eastman and High Performance Optics, Inc. (HPO) announced today that a selective High Energy Visible Light (HEVL) filtering window film for the transportation industry will be...
View ArticleClik here to view.
Aurion Biotech Receives Approval from Japan’s PMDA for New Drug Application
SEATTLE & CAMBRIDGE, Mass. & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has received...
View ArticleClik here to view.
Cellusion Announces First Patient Transplanted iPSC-Derived Corneal...
TOKYO Cellusion Inc. (CEO: Shin Hatou, M.D. Ph.D., “Cellusion”) announced that our research collaborator, Dr. Shigeto Shimmura, Professor of Fujita Health University and Keio University presented at...
View ArticleClik here to view.
OliX Pharmaceuticals Doses First Patient in Clinical Trial for RNAi...
SUWON, South Korea OliX Pharmaceuticals, Inc. (KOSDAQ: 226950), a leading developer of RNAi therapeutics, today announced that the first patient has been successfully dosed in a Phase 1 clinical...
View ArticleClik here to view.
Aurion Biotech Expands Its Leadership Team
SEATTLE, BOSTON & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has appointed Sherita Hall as...
View ArticleClik here to view.
Aurion Biotech Appoints Jonathan Sparks, JD, PhD as Chief Legal Officer
SEATTLE, BOSTON & TOKYO Aurion Biotech, whose mission is to restore vision to millions of patients with its life-changing regenerative therapies, today announced it has appointed Dr. Jonathan...
View ArticleClik here to view.
Conrad N. Hilton Foundation Awards more than $175 million from April through...
WESTLAKE VILLAGE, Calif. The Conrad N. Hilton Foundation announced today that the board of directors approved more than $175 million, including program-related investments, in the second and third...
View ArticleClik here to view.
STAAR Surgical Reports Preliminary Sales for Fourth Quarter and Fiscal 2022
LAKE FOREST, Calif. STAAR Surgical Company (NASDAQ: STAA), a leading developer, manufacturer and marketer of implantable lenses for the eye, today reported preliminary sales for the fourth quarter...
View ArticleClik here to view.
Novaliq计划于2023年7月在欧盟提交CyclASol®用于治疗干眼症的上市许可申请
德国海德堡和美国马萨诸塞州剑桥 (美国商业资讯)–Novaliq是一家生物制药公司，专注于基于独家EyeSol®无水技术的同类首创一流眼科治疗药物。公司今天宣布计划提交CyclASol®（环孢素眼药水）的上市许可申请(MAA)。这将是欧盟首款用于治疗干眼症(DED)的抗炎产品。...
View Article